News
Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that it has expanded its existing relationship and amended ...
The repurchases form part of the repurchase program of a maximum of 5,535,521 own ordinary shares for a total maximum amount of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback